NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 308,104 Value ($000) $265 Avg Close — Range —
Q3 2023
Shares 322,472 Value ($000) $345 Avg Close — Range —
Q2 2023
Shares 354,890 Value ($000) $919 Avg Close — Range —
Q1 2023
Shares 277,074 Value ($000) $1,130 Avg Close — Range —
Q4 2022
Shares 122,956 Value ($000) $617 Avg Close — Range —
Q3 2022
Shares 139,257 Value ($000) $1,821 Avg Close — Range —
Q2 2022
Shares 160,865 Value ($000) $2,062 Avg Close — Range —
Q1 2022
Shares 63,397 Value ($000) $967 Avg Close — Range —
Q4 2021
Shares 60,031 Value ($000) $1,063 Avg Close — Range —
Q3 2021
Shares 45,078 Value ($000) $948 Avg Close — Range —
Q2 2021
Shares 45,138 Value ($000) $890 Avg Close — Range —
Q1 2021
Shares 10,188 Value ($000) $296 Avg Close — Range —